Notable Wednesday Option Activity: UTHR, WYNN, VNDA

Wynn Resorts (WYNN) saw 19,101 options contracts trade (~1.9 million underlying shares), about 148.3% of its one‑month average daily share volume (1.3M); the $110 call expiring March 20, 2026 accounted for 15,632 contracts (~1.6M shares). Vanda Pharmaceuticals (VNDA) logged 22,662 options contracts (~2.3M underlying shares), ~147.5% of its one‑month average daily volume (1.5M), with the $8 call expiring January 16, 2026 trading 4,435 contracts (~443,500 shares). Such concentrated call activity and volumes materially above average may indicate directional positioning that could influence intraday equity moves.

Analysis

Market structure: The outsized call flow in WYNN (19,101 contracts ≈1.9M shares, 148% of ADV) and VNDA (22,662 contracts ≈2.3M shares, 147% of ADV) signals concentrated directional positioning—likely institutional directional buys or M&A/speculation—creating material delta exposure for market-makers. For WYNN the concentration at the Mar-20-2026 $110 call (15,632 contracts ≈1.6M shares) implies long-dated bullish convexity; for VNDA the Jan-16-2026 $8 call (4,435 contracts) points to short-term binary interest. That flow will steepen call skew and can induce short-term gamma-driven price moves independent of fundamentals.

Risk assessment: Immediate (days) risk is a gamma squeeze and IV repricing; short-term (weeks–months) risks include catalyst failures (VNDA trial/regulatory) or macro hits to travel (WYNN/Macau regulatory action or China mobility pullback). Tail risks: regulatory crackdowns in Macau, credit-rating pressure on WYNN’s leveraged balance sheet, and a failed pivotal readout or FDA setback for VNDA could cause >30–50% moves. Hidden dependencies include block trades, option synthetics, or hedged arb desks that can unwind positions abruptly; watch open interest decay into expiries.

Trade implications: Favor defined-risk option structures: for WYNN, buy long-dated call spreads (Mar-2026 110/140) sized to 1–2% NAV to capture skew while capping premium; for VNDA, buy Jan-2026 8/12 call spreads sized 0.5–1% as a binary asymmetric play. Pair trades: go long WYNN vs short LVS or MGM on 0.5:0.5 notional to isolate idiosyncratic upside; if IV for either rises >30% vs 60-day average, sell near-term calls to collect premium and fade front-month gamma.

Contrarian angles: The market may be mistaking speculative call flow for fundamental change—these blocks can be hedges for takeover risk or portfolio rebalancing, not pure conviction. Historical parallels (large concentrated call prints pre-buyouts and pre-exhaustion squeezes) suggest upside can be transient; if shares rally >15% without fundamental confirmation, expect mean-reversion. Unintended consequence: heavy dealer delta-hedging can create short-term liquidity vacuums leading to sharp reversals when positions are closed.

Key Decisions for Investors

• Establish a defined-risk WYNN position: buy Mar-20-2026 WYNN 110/140 call spread sized to 1.0–1.5% of NAV (max loss = premium) within next 7 trading days to capture bullish skew while limiting downside; trim half if WYNN rallies >15% intraday or if implied vol for WYNN falls below its 30-day median.
• Take a tactical VNDA binary bet: buy Jan-16-2026 VNDA 8/12 call spread sized to 0.5–1.0% NAV, expire or re-evaluate 30 days before Jan-2026 expiry; exit full position on any public M&A disclosure or failed clinical/regulatory news.
• Implement a relative-value casino trade: long WYNN equity (0.75–1.0% NAV) vs short LVS or MGM (equal notional) to isolate WYNN-specific upside from sector moves; rebalance if spread widens >10% or Macau footfall data (monthly) misses by >5% vs consensus.
• Use volatility as a cash-generator: if front-month IV for WYNN or VNDA spikes >30% above 60-day average, sell 30–60 day call credit spreads (size = 0.25–0.5% NAV) to harvest premium; close if underlying gaps >10% or IV normalizes to within 5% of 60-day average.